Zymeworks Inc
NASDAQ:ZYME
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.11
17.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Zymeworks Inc
Wall Street
Price Targets
ZYME Price Targets Summary
Zymeworks Inc
According to Wall Street analysts, the average 1-year price target for
ZYME
is 17.79 USD
with a low forecast of 12.12 USD and a high forecast of 29.4 USD.
ZYME Last Price Targets
Zymeworks Inc
The latest public price target was made on Nov 1, 2024 by
Derek Archila
from
Wells Fargo
,
who expects
ZYME
stock to
drop by 17%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Derek Archila
Wells Fargo
|
12
USD
Downside 17% |
3 weeks ago
Nov 1, 2024
|
Wells Fargo Downgrades Zymeworks (ZYME) to Equal Weight
StreetInsider
|
Stephen Willey
Stifel Nicolaus
|
28
USD
Upside 94% |
3 weeks ago
Oct 28, 2024
|
Zymeworks (ZYME) PT Raised to $28 at Stifel
StreetInsider
|
|
Robert Burns
H.C. Wainwright
|
12
USD
Downside 17% |
1 month ago
Sep 25, 2024
|
Zymeworks price target raised to $12 from $10 at H.C. Wainwright
TheFly
|
|
Andrew Berens
H.C. Wainwright
|
10
USD
Downside 31% |
2 months ago
Sep 18, 2024
|
H.C. Wainwright Reiterates Neutral Rating on Zymeworks (ZYME)
StreetInsider
|
|
Stephen Willey
Stifel Nicolaus
|
21
USD
Upside 46% |
2 months ago
Sep 10, 2024
|
Stifel Reiterates Buy Rating on Zymeworks (ZYME)
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ZYME's stock price target?
Price Target
17.79
USD
According to Wall Street analysts, the average 1-year price target for
ZYME
is 17.79 USD
with a low forecast of 12.12 USD and a high forecast of 29.4 USD.
What is Zymeworks Inc's Revenue forecast?
Projected CAGR
27%
For the last 8 years the
compound annual growth rate for
Zymeworks Inc's revenue is
29%.
The projected
CAGR
for the next 3 years is
27%.
You don't have any saved screeners yet
